E2F1 and TFDP1 Regulate PITX1 Expression in Normal and Osteoarthritic Articular Chondrocytes

Area of Science:

• Molecular Biology
• Genetics
• Biochemistry

Background:

• Osteoarthritis (OA) is characterized by a loss of PITX1 expression in articular chondrocytes.
• Aberrant nuclear accumulation of Prohibitin (PHB1), an E2F1 co-repressor, has been identified as a trigger for PITX1 repression in OA.

Purpose of the Study:

• To investigate the detailed involvement of E2F transcription factors in regulating PITX1 expression.
• To identify other genes regulated by E2F in the context of osteoarthritis.
• To elucidate the mechanism of PITX1 transcriptional regulation in articular chondrocytes.

Main Methods:

• Luciferase reporter assays and chromatin immunoprecipitation to analyze E2F1-PITX1 promoter interactions.
• DNA pulldown experiments to identify E2F1 binding sites in the PITX1 promoter.
• Real-time RT-PCR to measure mRNA expression levels of candidate genes in control and OA chondrocytes.
• Knockdown experiments of Transcription Factor Dp-1 (TFDP1) to assess the role of the E2F1-TFDP1 complex.

Main Results:

• Direct binding of E2F1 to two specific sequences in the PITX1 proximal promoter was confirmed.
• Overexpression of E2F1 enhanced PITX1 promoter activity and mRNA transcription.
• Knockdown of TFDP1 inhibited E2F1's activating effect, reducing PITX1 promoter activity and transcription.
• Reduced expression of TFDP1 and downregulation of its targets, including PITX1, BRCA1, CDKN1A, and RAD51, were observed in mid-stage OA chondrocytes.

Conclusions:

• E2F1 and TFDP1 play a significant role in the transcriptional regulation of PITX1 in articular chondrocytes.
• The E2F1-TFDP1 complex is crucial for maintaining PITX1 expression.
• Dysregulation of E2F1 targets, including PITX1, may contribute to osteoarthritis pathogenesis.